H. Abe, M. Takase, Y. Doi, S. Matsumoto, M. Furusyo, M. Inouye
FULL PAPER
poured into water (900 mL) and extracted with AcOEt
(100 mL×4). The AcOEt extract was washed with water
(200 mL×2) and brine (100 mL×2) subsequently, dried with
Na2SO4, and the solvents evaporated. The residue was purified by
silica gel column chromatography (hexane/AcOEt, 9:1) to afford 4
as colorless solid (2.8 g, 87%). M.p. 65–66 °C. 1H NMR (500 MHz,
CDCl3): δ = 0.88 (t, J = 7.3 Hz, 3 H), 1.26–1.38 (m, 8 H), 1.69–
1.72 (m, 2 H), 2.76 (t, J = 7.5 Hz, 2 H), 3.53 (s, 3 H), 5.52 (s, 2 H),
6.49 (s, 1 H), 7.83 (br. s, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 14.1, 22.6, 24.7, 29.1, 29.2, 31.7, 37.5, 57.8, 93.1, 102.1, 156.4,
for a cytosine base. The binding of 9 with cytosine was also
predicted to occur in a similar ADD·DAA mode.
Experimental Section
General Remarks: NMR spectra were recorded with a Varian
UNITY plus 500 instrument. Chemical shifts were given in ppm
relative to TMS (1H, 0.0 ppm) or CDCl3 (13C, 77.0 ppm). IR spec-
tra were obtained with a JASCO FTIR-460plus spectrometer. High
and low resolution mass spectra were taken with a JEOL JMS-
AX505HAD (EI) or a JEOL AccuTOF JMS T100LC (ESI) instru-
ments. Elemental analyses were performed with a Perkin–Elmer
2400II instrument. Melting points were measured with a Yanaco
MP-500D instrument and not corrected. UV/Vis and fluorescence
spectra were taken with a JASCO V-560 and a JASCO FP-6500
spectrometer, respectively. Vapor pressure osmometry (VPO) analy-
ses were performed with a Gonotec OSMOMAT 070 instrument.
Commercially available materials were used as purchased. Lipo-
philic nucleotides 10C,[20] 10G,[20] 10T,[21] and 10U[21] were prepared
according to the procedures in literature.
161.6, 170.0, 173.6 ppm. IR (KBr): ν = 3286, 2954, 2927, 2852,
˜
1689, 1563 cm–1. EI MS: m/z = 315 [M+]. C14H22ClN3O3 (315.8)
calcd. C 53.25, H 6.83, N 13.31; found C 53.20, H 6.83, N 13.30.
4-Chloro-6-(methoxymethoxy)-2-(octylamino)pyrimidine (5): To a
THF (10 mL) suspension of LiAlH4 (0.23 g, 6.0 mmol) was added
a THF (10 mL) solution of 4 (0.95 g, 3.0 mmol) dropwise at room
temperature. The suspension was slowly warmed and refluxed for
1 h. The resulting mixture was cautiously poured into an AcOEt/
satd. aq. NaHCO3/ice mixture and was extracted with AcOEt
(20 mL×3). The AcOEt extract was washed with satd. aq.
NaHCO3 twice and brine once, dried with Na2SO4, and the sol-
vents evaporated. The concentrated residue was purified by silica
gel column chromatography (hexane/AcOEt, 10:1) to afford 5 as
6-Chloro-2-(octanoylamino)-3H-pyrimidin-4-one (2): To an ice-cold
(0 °C) suspension of 2-amino-4-chloro-6-hydroxypyrimidine (1)
(4.4 g, 30 mmol) and 4-(dimethylamino)pyridine (DMAP) (8.1 g,
66 mmol) in DMF (60 mL) was added dropwise octanoyl chloride
(5.4 g, 33 mmol). The mixture was stirred for 5 h and slowly
brought to room temperature. The resulting solution was poured
into ice-water (600 mL), and the mixture was stirred for 10 h. The
precipitate formed was filtered and recrystallized from AcOEt to
afford colorless fibrous crystals of 2 (6.1 g, 77%). M.p. 236–237 °C.
1H NMR (500 MHz, CDCl3): δ = 0.89 (t, J = 7.0 Hz, 3 H), 1.28–
1.36 (m, 8 H), 1.69–1.72 (m, 2 H), 2.44 (t, J = 7.5 Hz, 2 H), 6.24
(s, 1 H), 8.50 (br. s, 1 H), 11.91 (br. s, 1 H) ppm. 13C NMR
(125 MHz, [D6]DMSO): δ = 13.9, 22.1, 24.2, 28.3, 28.4, 31.1, 36.0,
1
colorless solid (0.51 g, 56%). M.p. 33–35 °C. H NMR (500 MHz,
CDCl3): δ = 0.88 (t, J = 7.3 Hz, 3 H), 1.26–1.35 (m, 10 H), 1.53–
1.60 (m, 2 H), 3.34–3.39 (m, 2 H), 3.51 (s, 3 H), 5.1–5.5 (br. m, 3
H), 6.07 (s, 1 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 14.2,
22.7, 26.9, 29.28, 29.34, 29.5, 31.8, 41.6, 57.5, 92.2, 95.2, 96.2,
161.2, 161.7, 170.1 ppm. IR (KBr): ν = 3269, 2926, 2855, 1604,
˜
1579, 1536 cm–1. ESI HRMS: calcd. for C14H24ClN3NaO2 [M +
Na+] 324.1455; found 324.1447.
6-Chloro-2-(octylamino)-3H-pyrimidin-4-one (6): To a THF (6 mL)
solution of 5 (0.30 g, 1.0 mmol) was added 6 n HCl (6 mL), and
the mixture was stirred for 1 h at room temperature. The resulting
mixture was diluted with water (30 mL), made alkaline with
Na2CO3, and extracted with CHCl3 (10 mL×3). The CHCl3 ex-
tract was washed with brine and evaporated to afford 6 as colorless
solid (0.26 g, 100%). Further purification was carried out by silica
gel column chromatography (CH2Cl2/MeOH, 9:1). M.p. 161–
162 °C. 1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 7.0 Hz, 3 H),
1.25–1.38 (m, 10 H), 1.57–1.63 (m, 2 H), 3.38–3.42 (m, 2 H), 5.72
(s, 1 H), 6.64 (br. s, 1 H), 11.30 (br. s, 1 H) ppm. 13C NMR
(125 MHz, CDCl3): δ = 14.2, 22.7, 26.9, 29.2, 29.33, 29.35, 31.9,
106.9, 107.0, 151.0, 158.0, 159.8, 176.7 ppm. IR (KBr): ν = 3092,
˜
2925, 2857, 1667, 1599, 1558 cm–1. EI HRMS: m/z calcd. for
C12H18ClN3O2 [M+] 271.1088; found 271.1084.
2-(Octanoylamino)-6-(trimethylsilylethynyl)-3H-pyrimidin-4-one (3):
To a toluene (50 mL) suspension of 2 (0.50 g, 1.8 mmol) and
[Pd(PPh3)4] (0.21 g, 0.18 mmol) was added tri-n-butyl(trimethylsily-
lethynyl)stannane (2.1 g, 5.4 mmol) dropwise during 3 h at 80 °C.
The mixture was stirred additionally for 2 h at that temperature,
cooled to room temperature, and concentrated under a reduced
pressure. The resulting residue was purified by silica gel column
chromatography (hexane/AcOEt, 9:1) to give 3 (0.50 g, 81%). Fur-
ther purification can be done by recrystallization from hexane/Ac-
OEt (10:1) to afford colorless fibrous crystals. M.p. 167–174 °C. 1H
NMR (500 MHz, CDCl3): δ = 0.24 (s, 9 H), 0.87 (t, J = 7.0 Hz, 3
H), 1.26–1.33 (m, 8 H), 1.64–1.70 (m, 2 H), 2.38 (t, J = 7.5 Hz, 2
H), 6.30 (s, 1 H), 8.14 (br. s, 1 H), 11.81 (br. s, 1 H) ppm. 13C
NMR (125 MHz, [D6]DMSO): δ = –0.6, 13.9, 22.1, 24.2, 28.28,
28.35, 31.1, 36.0, 98.3, 101.9, 112.2, 112.4, 146.6, 151.4, 159.8,
41.3, 99.7, 153.8, 162.6, 164.7 ppm. IR (KBr): ν = 3259, 2953, 2929,
˜
2848, 1671, 1623 cm–1. EI HRMS: calcd. for C12H20ClN3O [M+]
257.1295; found 257.1297.
2-(Octylamino)-6-(trimethylsilylethynyl)-3H-pyrimidin-4-one (7): A
xylene (30 mL) solution of 6 (179 mg, 0.69 mmol) and [Pd(PPh3)4]
(80 mg, 0.07 mmol) was heated to 120 °C, then to the mixture was
added
tri-n-butyl(trimethylsilylethynyl)stannane
(1.34 g,
3.45 mmol) in one portion. The mixture was stirred for 3 h at
120 °C, cooled to room temperature, and diluted with CHCl3
(30 mL). The organic layer was washed with brine twice, dried with
Na2SO4, and the solvents evaporated. The resulting residue was
purified by silica gel column chromatography (CH2Cl2/MeOH,
10:1) twice and preparative reverse phase HPLC (COSMOSIL
5SL-II, Nacalai Tesque, Inc.; MeOH/water, 9:1) to afford 7 (48 mg,
22%) as colorless solid. M.p. 34–36 °C. 1H NMR (500 MHz,
CDCl3): δ = 0.25 (s, 9 H), 0.88 (t, J = 7.0 Hz, 3 H), 1.28–1.39 (m,
10 H), 1.57–1.62 (m, 2 H), 3.39–3.43 (m, 2 H), 5.86 (s, 1 H), 6.56
(br. s, 1 H), 11.22 (br. s, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = –0.34, 14.2, 22.7, 26.9, 29.27, 29.33, 29.34, 31.9, 41.1, 98.3,
176.6 ppm. IR (KBr): ν = 3154, 2925, 2856, 1647 cm–1. EI HRMS:
˜
m/z calcd. for C17H27N3O2Si [M+] 333.1873; found 333.1870.
4-Chloro-6-(methoxymethoxy)-2-(octanoylamino)pyrimidine (4): To
an ice-cold (0 °C) suspension of NaH (0.44 g, 11 mmol; commercial
60% dispersion was washed thoroughly with hexane prior to use)
and K2CO3 (3.0 g, 22 mmol) in DMF (200 mL) was slowly added
2 (2.7 g, 10 mmol). After stirring for 1 h at 0 °C, chloromethyl
methyl ether (MOMCl) (0.89 g, 11 mmol) was added to the suspen-
sion. The mixture was stirred for an additional 24 h, being slowly
warmed from 0 °C to room temperature. The resulting mixture was
2938
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 2931–2940